FDA ADVISERS CLEAR VIVUS OBESITY DRUG

被引：0

|

作者：

不详

机构：

来源：

CHEMICAL & ENGINEERING NEWS | 2012年 / 90卷 / 09期

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

收藏

页码：19 / 19

页数：1

相关论文

共 50 条

[1] FDA advisers warn of more deaths if drug is relaunched
Moynihan, R
[J]. BRITISH MEDICAL JOURNAL, 2002, 325 (7364): : 561 - 561
[2] FDA advisers to assess drug for low sexual desire in women
Moynihan, Ray
[J]. BRITISH MEDICAL JOURNAL, 2010, 340
[3] Drug for low sexual desire carries significant harms, FDA advisers find
Moynihan, Ray
[J]. BRITISH MEDICAL JOURNAL, 2010, 341
[4] FDA ADVISERS OKAY NEXSTARS DAUNOXOME
FOX, JL
[J]. BIO-TECHNOLOGY, 1995, 13 (07): : 635 - 636
[5] FDA advisers wary of expanding quetiapine use
Traynor, Kate
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (10) : 880 - +
[6] FDA ADVISERS SPURN TOUGH DARVON CONTROLS
SMITH, RJ
[J]. SCIENCE, 1979, 204 (4394) : 712 - 713
[7] FDA advisers find no major Halcion danger
Ault, A
[J]. LANCET, 1997, 350 (9093): : 1760 - 1760
[8] FDA advisers vote against nonprescription lovastatin
Traynor, K
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (05) : 455 - +
[9] FDA advisers again reject nonprescription lovastatin
Traynor, Kate
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (02) : 101 - +
[10] FDA advisers recommend approval of biosimilar filgrastim
Traynor, Kate
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (04) : 262 - +

← 1 2 3 4 5 →